BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heier MS, Skinningsrud A, Paus E, Gautvik KM. Increased cerebrospinal fluid levels of nerve cell biomarkers in narcolepsy with cataplexy. Sleep Med 2014;15:614-8. [PMID: 24784789 DOI: 10.1016/j.sleep.2014.02.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Cedernaes J, Osorio RS, Varga AW, Kam K, Schiöth HB, Benedict C. Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease. Sleep Med Rev 2017;31:102-11. [PMID: 26996255 DOI: 10.1016/j.smrv.2016.02.002] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 15.8] [Reference Citation Analysis]
2 Marques TM, Van Rumund A, Kuiperij HB, Verbeek MM. Biomarkers in cerebrospinal fluid for synucleinopathies, tauopathies, and other neurodegenerative disorders. Cerebrospinal Fluid in Neurologic Disorders. Elsevier; 2018. pp. 99-113. [DOI: 10.1016/b978-0-12-804279-3.00007-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gabelle A, Jaussent I, Bouallègue FB, Lehmann S, Lopez R, Barateau L, Grasselli C, Pesenti C, de Verbizier D, Béziat S, Mariano-Goulart D, Carlander B, Dauvilliers Y; Alzheimer's Disease Neuroimaging Initiative., Multi-Domain Intervention Alzheimer's Prevention Trial study groups. Reduced brain amyloid burden in elderly patients with narcolepsy type 1. Ann Neurol 2019;85:74-83. [PMID: 30387527 DOI: 10.1002/ana.25373] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
4 Heier M, Gautvik K. What happens in the brain in narcolepsy over time? Sleep Medicine 2014;15:1427. [DOI: 10.1016/j.sleep.2014.07.003] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Mander BA, Winer JR, Jagust WJ, Walker MP. Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease? Trends Neurosci 2016;39:552-66. [PMID: 27325209 DOI: 10.1016/j.tins.2016.05.002] [Cited by in Crossref: 201] [Cited by in F6Publishing: 179] [Article Influence: 33.5] [Reference Citation Analysis]
6 Berhe DF, Gebre AK, Assefa BT. Orexins role in neurodegenerative diseases: From pathogenesis to treatment. Pharmacol Biochem Behav 2020;194:172929. [PMID: 32315694 DOI: 10.1016/j.pbb.2020.172929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Peyron C, Seugnet L, Lin JS. Commentary: A Quest for a Novel Peripheral Biomarker for Narcolepsy. CNS Neurosci Ther 2015;21:681-2. [PMID: 26281778 DOI: 10.1111/cns.12433] [Reference Citation Analysis]
8 Baiardi S, Pizza F, Polischi B, Moresco M, Abu-Rumeileh S, Plazzi G, Parchi P. Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1. Sleep 2020;43:zsz215. [PMID: 31552425 DOI: 10.1093/sleep/zsz215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Liguori C, Placidi F, Izzi F, Albanese M, Nuccetelli M, Bernardini S, Marciani MG, Mercuri NB, Romigi A. May CSF beta-amyloid and tau proteins levels be influenced by long treatment duration and stable medication in narcolepsy? Sleep Medicine 2014;15:1424. [DOI: 10.1016/j.sleep.2014.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
10 Sarkanen T, Alakuijala A, Partinen M. Clinical course of H1N1-vaccine-related narcolepsy. Sleep Medicine 2016;19:17-22. [DOI: 10.1016/j.sleep.2015.11.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
11 Shan L, Dauvilliers Y, Siegel JM. Interactions of the histamine and hypocretin systems in CNS disorders. Nat Rev Neurol 2015;11:401-13. [PMID: 26100750 DOI: 10.1038/nrneurol.2015.99] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
12 Berteotti C, Liguori C, Pace M. Dysregulation of the orexin/hypocretin system is not limited to narcolepsy but has far-reaching implications for neurological disorders. Eur J Neurosci 2021;53:1136-54. [PMID: 33290595 DOI: 10.1111/ejn.15077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Liguori C, Placidi F, Izzi F, Nuccetelli M, Bernardini S, Sarpa MG, Cum F, Marciani MG, Mercuri NB, Romigi A. Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time. Sleep Breath 2016;20:277-83. [DOI: 10.1007/s11325-015-1305-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]